NCI Weighs Every Patient Cancer Data Initiative

The National Cancer Institute is considering a program to collect cancer information on every U.S. patient treated for the disease.

Updated on Nov. 13, 2026 in Cancer

NCI Weighs Every Patient Cancer Data Initiative

Live Poll

Are you comfortable with AI reviewing your medical records for cancer research?

The director of the National Cancer Institute said the agency is considering an initiative called "Every Patient" to obtain cancer-related information for every U.S. patient treated for cancer. The announcement came at the Milken summit on Thursday.

Why it matters

The National Cancer Institute still misses information about patients despite its designated centers and cooperative groups, and the initiative aims to close that gap. Broader patient data would give researchers a fuller picture of how cancer is treated across the country.

The National Cancer Institute supports 74 designated cancer centers that deliver care with federal funds, and a $200 million effort to develop a therapeutic cancer vaccine was announced alongside. Funding details for the Every Patient initiative and its decision timeline have not been disclosed.

The players

National Cancer Institute

The National Cancer Institute is the federal agency within the National Institutes of Health that leads U.S. government cancer research and funds designated cancer centers across the country.

The details

The director said the agency is considering Every Patient, which would obtain cancer-related information for every U.S. patient treated for cancer. Separately, the National Cancer Institute and the Foundation for the National Institutes of Health announced a $200 million effort to develop a therapeutic cancer vaccine, with AI expected to aid the work.

Thursday, November 12, 2026: Director announced Every Patient consideration at the Milken summit.

Big Picture

The proposal builds on the National Cancer Institute's 74-center designated cancer network, which already delivers federally funded care. It extends that framework by seeking cancer information on every U.S. patient, not only those treated at designated centers.

If adopted, Every Patient would mean cancer information about U.S. patients is collected more systematically, which could affect how care is studied. Patients treated for cancer may eventually be part of this data collection, though consent arrangements have not been described.

The takeaway

Broader cancer data collection and AI-supported research could help researchers identify clinical trial candidates and new treatment targets faster. Patients interested in trials can ask their care team whether their records may be reviewed for eligibility.